Literature DB >> 12894129

Current systemic therapies for psoriasis: where are we now?

Paul S Yamauchi1, Dalia Rizk, Tanya Kormeili, Rickie Patnaik, Nicholas J Lowe.   

Abstract

Many systemic agents are used in the treatment of psoriasis. They provide good control of psoriasis in the majority of patients and have improved their life quality indices. Frequently, combination therapy is utilized to synergize the efficacy of these medications. Many dermatologists are hesitant in prescribing systemic agents because of their adverse effects. However, such potential toxicities arising from these medications can largely be avoided if proper patient selection and close monitoring are performed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894129     DOI: 10.1016/mjd.2003.550

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  3 in total

1.  Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-11-01

Review 2.  The long-term efficacy and safety of new biological therapies for psoriasis.

Authors:  Kim A Papp
Journal:  Arch Dermatol Res       Date:  2006-04-25       Impact factor: 3.017

3.  Simultaneous thrombosis of multiple coronary arteries in a patient with rheumatoid arthritis.

Authors:  Arzu Kalayci; Erol Arslan; Salih Murat Bakar; Mahmut Guneri; Rafet Dizman; Eylem Kivanc; Can Yucel Karabay
Journal:  J Cardiovasc Thorac Res       Date:  2016-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.